IL148379A0 - Pharmaceutical solutions of levosimendan - Google Patents

Pharmaceutical solutions of levosimendan

Info

Publication number
IL148379A0
IL148379A0 IL14837900A IL14837900A IL148379A0 IL 148379 A0 IL148379 A0 IL 148379A0 IL 14837900 A IL14837900 A IL 14837900A IL 14837900 A IL14837900 A IL 14837900A IL 148379 A0 IL148379 A0 IL 148379A0
Authority
IL
Israel
Prior art keywords
levosimendan
pharmaceutical solutions
pharmaceutical
solutions
Prior art date
Application number
IL14837900A
Other languages
English (en)
Original Assignee
Orion Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8555263&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL148379(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Orion Corp filed Critical Orion Corp
Publication of IL148379A0 publication Critical patent/IL148379A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
IL14837900A 1999-09-10 2000-09-08 Pharmaceutical solutions of levosimendan IL148379A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI991925A FI109659B (fi) 1999-09-10 1999-09-10 Levosimendaanin farmaseuttisia liuoksia
PCT/FI2000/000761 WO2001019334A2 (fr) 1999-09-10 2000-09-08 Solutions pharmaceutiques de levosimendan

Publications (1)

Publication Number Publication Date
IL148379A0 true IL148379A0 (en) 2002-09-12

Family

ID=8555263

Family Applications (2)

Application Number Title Priority Date Filing Date
IL14837900A IL148379A0 (en) 1999-09-10 2000-09-08 Pharmaceutical solutions of levosimendan
IL148379A IL148379A (en) 1999-09-10 2002-02-26 Pharmacist solutions of Livsimanden

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL148379A IL148379A (en) 1999-09-10 2002-02-26 Pharmacist solutions of Livsimanden

Country Status (39)

Country Link
US (2) US6730673B1 (fr)
EP (1) EP1210085B1 (fr)
JP (1) JP4708648B2 (fr)
KR (1) KR100869752B1 (fr)
CN (1) CN1203855C (fr)
AR (1) AR025449A1 (fr)
AT (1) ATE315937T1 (fr)
AU (1) AU771027B2 (fr)
BG (1) BG65827B1 (fr)
BR (1) BRPI0013924B8 (fr)
CA (1) CA2382013C (fr)
CO (1) CO5180582A1 (fr)
CZ (1) CZ303095B6 (fr)
DE (1) DE60025627T2 (fr)
DK (1) DK1210085T3 (fr)
EA (1) EA005067B1 (fr)
EE (1) EE05375B1 (fr)
ES (1) ES2256034T3 (fr)
FI (1) FI109659B (fr)
HK (1) HK1049282B (fr)
HR (1) HRP20020298B1 (fr)
HU (1) HU228340B1 (fr)
IL (2) IL148379A0 (fr)
IS (1) IS2244B (fr)
ME (1) ME00523B (fr)
MX (1) MXPA02002423A (fr)
MY (1) MY125984A (fr)
NO (1) NO331989B1 (fr)
NZ (1) NZ517605A (fr)
PL (1) PL202356B1 (fr)
PT (1) PT1210085E (fr)
RS (1) RS50445B (fr)
SI (1) SI1210085T1 (fr)
SK (1) SK287154B6 (fr)
TR (1) TR200200620T2 (fr)
TW (1) TWI242434B (fr)
UA (1) UA73954C2 (fr)
WO (1) WO2001019334A2 (fr)
ZA (1) ZA200201828B (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI109659B (fi) * 1999-09-10 2002-09-30 Orion Yhtymae Oyj Levosimendaanin farmaseuttisia liuoksia
FI20010233A0 (fi) * 2001-02-08 2001-02-08 Orion Corp Menetelmä sydämen vajaatoiminnan hoitoon
CN100428937C (zh) * 2003-10-30 2008-10-29 北京海合天科技开发有限公司 左西孟旦冷冻干燥组合物
CN100367964C (zh) * 2004-04-29 2008-02-13 王思清 左西孟旦-β环糊精包含物制剂
CA2596768A1 (fr) * 2005-02-18 2006-08-24 Orion Corporation Technique de traitement d'insuffisance cardiaque
JP2010514778A (ja) * 2006-12-28 2010-05-06 オリオン コーポレーション 非経口投与のためのレボシメンダン製剤
WO2012093404A2 (fr) 2011-01-03 2012-07-12 Gufic Biosciences Limited Formulations parentérales de lévosimendane
US9597425B2 (en) * 2011-10-18 2017-03-21 St. Teresa Medical, Inc. Method of forming a hemostatic product
MX369832B (es) * 2012-05-18 2019-11-22 Luoda Pharma Ltd Formulaciones líquidas que comprenden pimobendan y propilenglicol para el tratamiento de hipertensión y/o enfermedades cardiacas.
CN105106113B (zh) * 2015-09-30 2019-07-26 济南康和医药科技有限公司 一种左西孟旦注射液及其制备方法
CA3004362C (fr) * 2015-11-06 2022-10-04 Carinopharm Gmbh Formulations ameliorees de levosimendane pour administration intraveineuse par perfusion ou injection et de concentre pour perfusion
US10828387B2 (en) 2015-11-12 2020-11-10 St. Teresa Medical, Inc. Method of sealing a durotomy
CN108261398A (zh) * 2016-12-30 2018-07-10 齐鲁制药有限公司 一种含有左西孟旦的供注射用药物制剂及其制备方法
WO2019089717A1 (fr) 2017-11-02 2019-05-09 St. Teresa Medical, Inc. Produits de scellement à base de fibrine
CN111474289A (zh) * 2019-10-31 2020-07-31 武汉嘉诺康医药技术有限公司 一种利用反相色谱分离分析左西孟旦中右西孟旦的方法
CA3161960A1 (fr) * 2019-12-16 2021-06-24 Tenax Therapeutics, Inc. Levosimendan pour traiter l'hypertension pulmonaire accompagnee d'une insuffisance cardiaque au moyen d'une fraction d'ejection preservee (ph-hfpef)
CN111514147B (zh) * 2020-05-12 2021-09-17 成都欣捷高新技术开发股份有限公司 用于急性失代偿心力衰竭症状的左西孟旦钠药用组合物及制备方法
US11760730B2 (en) * 2021-01-11 2023-09-19 Navinta, Llc Process for the preparation of high purity Levosimendan
WO2023027670A2 (fr) * 2021-08-23 2023-03-02 Tum Ekip Ilac Anonim Sirketi Compositions de lévosimendan lyophilisées
CN115518037A (zh) * 2022-10-14 2022-12-27 上药东英（江苏）药业有限公司 一种安全质量稳定的左西孟旦注射剂组合物及其制备方法
CN116473930B (zh) * 2023-05-17 2023-12-15 山东泰合医药科技有限公司 一种注射用左西孟旦及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2251615B (en) 1991-01-03 1995-02-08 Orion Yhtymae Oy (-)-[[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl]hydrazono]pro panedinitrile
GB2266841A (en) 1992-05-06 1993-11-17 Orion Yhtymae Oy Compounds for use as anti-ischemic medicaments
GB9606474D0 (en) 1996-03-27 1996-06-05 Orion Yhytmo Oy Method for obtaining pure enantiomers of a pyridazinone derivative
GB9614098D0 (en) 1996-07-05 1996-09-04 Orion Yhtymae Oy Transdermal delivery of levosimendan
FI980902A (fi) * 1998-04-23 1999-10-24 Orion Yhtymae Oyj Levosimendaanin stabiileja koostumuksia
FI109659B (fi) * 1999-09-10 2002-09-30 Orion Yhtymae Oyj Levosimendaanin farmaseuttisia liuoksia

Also Published As

Publication number Publication date
PL202356B1 (pl) 2009-06-30
BG65827B1 (bg) 2010-02-26
EE05375B1 (et) 2011-02-15
BR0013924B1 (pt) 2013-09-24
NZ517605A (en) 2003-08-29
TWI242434B (en) 2005-11-01
MXPA02002423A (es) 2002-08-12
EE200200129A (et) 2003-04-15
CN1373665A (zh) 2002-10-09
BRPI0013924B8 (pt) 2021-05-25
NO20021090L (no) 2002-03-05
US20040106617A1 (en) 2004-06-03
BG106589A (bg) 2002-11-29
TR200200620T2 (tr) 2002-09-23
CN1203855C (zh) 2005-06-01
IS6296A (is) 2002-03-06
CZ2002788A3 (cs) 2002-11-13
HK1049282A1 (en) 2003-05-09
SK3272002A3 (en) 2002-12-03
IL148379A (en) 2006-12-10
NO20021090D0 (no) 2002-03-05
FI19991925A (fi) 2001-03-10
HU228340B1 (en) 2013-03-28
FI109659B (fi) 2002-09-30
ME00523B (me) 2011-10-10
NO331989B1 (no) 2012-05-21
PT1210085E (pt) 2006-05-31
EP1210085B1 (fr) 2006-01-18
DE60025627D1 (de) 2006-04-06
AU771027B2 (en) 2004-03-11
US6730673B1 (en) 2004-05-04
SI1210085T1 (sl) 2006-04-30
JP4708648B2 (ja) 2011-06-22
JP2003509351A (ja) 2003-03-11
AU7004400A (en) 2001-04-17
DE60025627T2 (de) 2006-11-16
HRP20020298B1 (en) 2007-02-28
CZ303095B6 (cs) 2012-03-28
DK1210085T3 (da) 2006-05-08
ES2256034T3 (es) 2006-07-16
MY125984A (en) 2006-09-29
BR0013924A (pt) 2002-05-21
US6943164B2 (en) 2005-09-13
KR100869752B1 (ko) 2008-11-21
PL354028A1 (en) 2003-12-15
CO5180582A1 (es) 2002-07-30
HUP0202749A3 (en) 2003-03-28
CA2382013C (fr) 2009-08-11
EA200200348A1 (ru) 2002-08-29
IS2244B (is) 2007-05-15
SK287154B6 (sk) 2010-01-07
RS50445B (sr) 2010-03-02
CA2382013A1 (fr) 2001-03-22
AR025449A1 (es) 2002-11-27
KR20020048400A (ko) 2002-06-22
ATE315937T1 (de) 2006-02-15
HUP0202749A2 (hu) 2003-02-28
UA73954C2 (uk) 2005-10-17
WO2001019334A2 (fr) 2001-03-22
EA005067B1 (ru) 2004-10-28
HRP20020298A2 (en) 2003-06-30
HK1049282B (zh) 2005-12-30
EP1210085A2 (fr) 2002-06-05
YU16902A (sh) 2004-09-03
ZA200201828B (en) 2003-08-27
WO2001019334A3 (fr) 2001-11-15

Similar Documents

Publication Publication Date Title
HUP0202749A3 (en) Pharmaceutical solutions of levosimendan
HK1040995A1 (zh) 二氧喹啉化合物及其醫藥用途
HUP0203585A3 (en) Pharmaceutical combinations
HK1042241A1 (zh) 膠囊系統
EG23858A (en) Drug combination
IL145632A0 (en) Pharmaceutical compounds
GB9916434D0 (en) Pharmaceutical compounds
GB9914255D0 (en) Pharmaceutical compounds
IL146341A0 (en) Pharmaceutical complex
GB9903784D0 (en) Pharmaceutical compounds
GB9924158D0 (en) Nebuliser
GB2373499B (en) Pharmaceutical compounds
GB9924990D0 (en) Medicaments
GB9929040D0 (en) Medicaments
GC0000150A (en) Pharmaceutical solutions of levosimendan.
GB9904935D0 (en) Medicaments
GB9929039D0 (en) Medicaments
GB9926434D0 (en) Pharmaceutical
GB9926437D0 (en) Pharmaceutical
GB9911499D0 (en) Medicament
GB9929405D0 (en) Medicament
SI1169298T1 (sl) Framacevtske spojine
SI1252133T1 (en) Pharmaceutical compounds
GB9921064D0 (en) Drug combination
HU9902398D0 (en) Pharmaceutical preparation

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed